Hormone therapy for<unk>  individuals has been shown in medical literature to be generally safe, when supervised by a qualified medical professional. There are potential risks with hormone treatment that will be monitored through screenings and lab tests such as blood count (hemoglobin), kidney and liver function, blood sugar, potassium, and cholesterol. Taking more medication than directed may lead to health problems such as increased risk of cancer, heart attack from thickening of the blood, blood clots, and elevated cholesterol. Feminizing hormone therapy The Standards of Care published by the World Professional Association for<unk>  Health (WPATH) summarize many of the risks associated with feminizing hormone therapy (outlined below). For more in-depth information on the safety profile of estrogen-based feminizing hormone therapy visit the feminizing hormone therapy page. +Summary of Risks of Estrogen Therapy Likely Increased Risk Possible Increased Risk Inconclusive/No Increased Risk Venous Thromboembolic Disease Type 2 Diabetes Mellitus Breast Cancer Cardiovascular Events Hypertension Increase Triglycerides Increased Prolactin Transient Increase in Liver Enzymes Gall Stones Masculinizing hormone therapy The Standards of Care published by the World Professional Association for<unk>  Health (WPATH) summarize many of the risks associated with masculinizing hormone therapy (outlined below). For more in-depth information on the safety profile of testosterone-based masculinizing hormone therapy visit the masculinizing hormone therapy page. +Summary of Risks of Testosterone Therapy Likely Increased Risk Possible Increased Risk Inconclusive/No Increased Risk Polycythemia Decreased HDL Osteoporosis Weight Gain Transient Increase in Liver Enzymes Cardiovascular Events Hypertension Breast, Cervical, Ovarian, Endometrial Cancer Fertility consideration<unk>  may limit fertility potential. Should a<unk>  individual choose to undergo sex reassignment surgery, their fertility potential is lost completely. Before starting any treatment, individuals may consider fertility issues and fertility preservation. Options include semen cryopreservation, oocyte cryopreservation, and ovarian tissue cryopreservation. A study due to be presented at ENDO 2019 (the Endocrine Society's conference) reportedly shows that even after one year of treatment with testosterone, a<unk>  man can preserve his fertility potential.
Transgender hormone therapy
Feminizing hormone therapy
Androgen replacement therapy
Sex reassignment therapy
Masculinizing hormone therapy
Sex reassignment surgery 
Sex reassignment surgery
Hormone therapy